IP Summit: Changes In Patent System, Intermediary Liability And The Future Of IP 04/12/2015 by Monika Ermert for Intellectual Property Watch Leave a Comment The stretch run for Europe’s Unitary Patent System (UPS) again took centre stage at the Premier Cercle IP Summit 2015 in Berlin yesterday. Eyes are on Germany for the ratification of the UPS. Cornelia Rudloff-Schäffer, president of the German Patent Office, in the keynote speech assured the 300 hundred participants Germany was preparing for the new system and called out to industry to prepare for the change, saying: “Check your portfolio now.”
Speakers At WIPO Diverge On Patents-Access Relationship; Biologics A Challenge For Generics 03/12/2015 by Catherine Saez, Intellectual Property Watch 3 Comments A seminar on patents and availability of medicines in developing countries yesterday considered whether patents constitute a barrier to access. For the private sector, patents are essential to the innovation system, for others they maintain high prices and should be licensed for easier access. Beyond patents, biologics seem to be taking over the pharmaceutical industry, and the complexity of manufacturing biosimilars might well leave traditional generic manufacturers by the wayside. Separately, a side event at WIPO looked at IP management strategies in private-public partnerships in agriculture and health technologies.
Medicines Patent Pool Partners with Liverpool University On HIV Nanomedicines 01/12/2015 by Intellectual Property Watch Leave a Comment The Medicines Patent Pool has signed a collaborative agreement with the University of Liverpool to develop HIV nanomedicines.
WIPO Patent Law Committee Looks At Access To Medicines, Confidentiality 30/11/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Intellectual Property Organization committee on patent law is meeting this week, including a half-day seminar on the relationship between patent systems and the availability of medicines in developing countries and least-developed countries.
Medicines Patent Pool: First Licence Agreement For Hepatitis C Drug 23/11/2015 by Intellectual Property Watch Leave a Comment The Medicines Patent Pool announced today that it signed a first licence for a hepatitis C drug with Bristol-Myers Squibb. The agreement allows manufacturing of daclatasvir, royalty-free in 112 low-and middle-income countries.
Panel Looks At Patentability Criteria In Public Health 11/11/2015 by Catherine Saez, Intellectual Property Watch Leave a Comment A recent workshop on patentability criteria illustrated how countries are using the policy space provided by international trade rules to calibrate their patent law. In particular, incremental innovation remains a trying issue for national legislators, speakers said.
Medicines Patent Pool Expands To Include Hepatitis C, Tuberculosis 09/11/2015 by Intellectual Property Watch 1 Comment The Medicines Patent Pool has announced the expansion of its mandate to cover hepatitis C and tuberculosis treatment. The MPP was previously concentrating only on HIV medicines.
Public Health Considerations Should Guide Patent Examination, Paper Argues 05/11/2015 by Intellectual Property Watch Leave a Comment Patent offices should align their work in support of national health and medicines policies when carrying out the examination of patents, a new South Centre paper argues.
17 Year Exemption From Pharmaceutical Patents Agreed At WTO – TWN 03/11/2015 by Intellectual Property Watch, Intellectual Property Watch 1 Comment From Third World Network: London, 3 Nov (Sangeeta Shashikant) The United States and the Least Developed Countries (LDCs) at the World Trade Organization have reached agreement ad referendum on a pharmaceutical patent exemption for a duration of 17 years, according to trade diplomats.
Kenya Considers Lifting Ban On GMOs; Seed Patents In Debate 28/10/2015 by Fredrick Nzwili for Intellectual Property Watch 2 Comments NAIROBI, Kenya – A Kenyan government plan to lift the ban on genetically modified organisms (GMOs) is stirring a heated debate here, with experts warning on safety and the East African nation’s preparedness for the technology.